Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries

The hexavalent vaccines DT3aP-HBV-IPV/Hib and DT2aP-HBV-IPV-Hib are routinely used for primary immunization of infants against diphtheria, tetanus, pertussis, hepatitis B virus, poliomyelitis, and Haemophilus influenzae type b. A recent publication showed that after primary immunization with these v...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Marina, Pérez Martin, Jaime, AbdelGhany, Mohammad, Gkalapi, Foteini, Jamet, Nicolas, Kosse, Richelle C., Ruiz García, Yara, Turriani, Elisa, Berlaimont, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Licensed Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294728/
https://www.ncbi.nlm.nih.gov/pubmed/37102330
http://dx.doi.org/10.1080/21645515.2023.2202124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294728/
https://www.ncbi.nlm.nih.gov/pubmed/37102330
http://dx.doi.org/10.1080/21645515.2023.2202124

Ejemplares similares